Literature DB >> 7539120

Evaluation of the cytokine response in Kawasaki disease.

B A Eberhard1, U Andersson, R M Laxer, V Rose, E D Silverman.   

Abstract

Intracellular cytokines interleukin 6, tumor necrosis factor (TNF) alpha and TNF-beta were studied in peripheral blood mononuclear cells of patients with Kawasaki disease during the acute, subacute and convalescent stages of the disease utilizing cytokine-specific monoclonal antibodies and indirect immunofluorescence. Intracellular cytokines TNF-alpha and -beta were present only during the acute stage before initiation of therapy and not in the subacute or convalescent phase. Intracellular interleukin 6 was seen in both the acute phase and, in small numbers of patients, in the subacute stage of the illness. Overall 15 of 25 (60%) patients produced at least one intracellular cytokine. In the acute stage both monocyte and lymphocyte cytokines were detected intracellularly, TNF-alpha and TNF-beta in 58% of patients whereas interleukin 6 was seen in only 16%. This study provides evidence to support the involvement of activated mononuclear cells, both T cells and monocytes and their secreted soluble products, cytokines, in the pathogenesis of Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539120     DOI: 10.1097/00006454-199503000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

2.  Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Authors:  K Ikeda; K Yamaguchi; T Tanaka; Y Mizuno; A Hijikata; O Ohara; H Takada; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

3.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.

Authors:  Tetsuya Sano; Shunji Kurotobi; Kouji Matsuzaki; Takehisa Yamamoto; Ichiro Maki; Kazunori Miki; Shigetoyo Kogaki; Junichi Hara
Journal:  Eur J Pediatr       Date:  2006-08-01       Impact factor: 3.183

4.  Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.

Authors:  M Gupta; G J Noel; M Schaefer; D Friedman; J Bussel; R Johann-Liang
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

5.  Serum resistin concentrations in children with Kawasaki disease.

Authors:  Hiroki Nozue; Hironori Imai; Hisako Saitoh; Takeshi Aoki; Kunio Ichikawa; Tomohiro Kamoda
Journal:  Inflamm Res       Date:  2010-04-27       Impact factor: 4.575

6.  The CCR5 (-2135C/T) polymorphism may be associated with the development of Kawasaki disease in Korean children.

Authors:  Won Kyoung Jhang; Mi-Jin Kang; Hyun-Seung Jin; Jinho Yu; Byoung-ju Kim; Bong Seong Kim; Jong-Keuk Lee; Eul-Ju Seo; Han-Wook Yoo; In Sook Park; Young Mi Hong; Soo-Jong Hong
Journal:  J Clin Immunol       Date:  2008-07-15       Impact factor: 8.317

7.  Fasciola hepatica induces Foxp3 T cell, proinflammatory and regulatory cytokine overexpression in liver from infected sheep during early stages of infection.

Authors:  Isabel L Pacheco; Nieves Abril; Rafael Zafra; Verónica Molina-Hernández; Noelia Morales-Prieto; María J Bautista; María T Ruiz-Campillo; Raúl Pérez-Caballero; Alvaro Martínez-Moreno; José Pérez
Journal:  Vet Res       Date:  2018-07-03       Impact factor: 3.683

8.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31

9.  Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease.

Authors:  Kai-Chung Hsueh; Ying-Ju Lin; Jeng-Sheng Chang; Lei Wan; Yu-Hsin Tsai; Chang-Hai Tsai; Chih-Ping Chen; Fuu-Jen Tsai
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

10.  Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via activating amp-activated protein kinase (AMPK) signaling.

Authors:  Jian-Li Zhang; Ying Xu; Jie Shen
Journal:  Int J Mol Sci       Date:  2014-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.